Antisense Therapeutics Ltd. (OTC: ATHJF) is an Australian pharmaceutical drug discovery and development company whose mission is to create, develop and commercialize novel antisense therapeutics. One of Antisense Therapeutics’ fundamental strategies is acquiring access to state of the art antisense technology, in both know-how and intellectual property, to accelerate drug discovery and development. For more information, visit the company’s website at www.antisense.com.au.